Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:EXAC
- CUSIP: 30064E10
- Web: www.exac.com
Capitalization:- Market Cap: $449.09 million
- Outstanding Shares: 14,348,000
Average Prices:- 50 Day Moving Avg: $29.72
- 200 Day Moving Avg: $29.00
- 52 Week Range: $22.20 - $32.00
P/E:- Trailing P/E Ratio: 601.92
- Foreward P/E Ratio: 21.29
- P/E Growth: 2.37
Sales & Book Value:- Annual Revenue: $262.96 million
- Price / Sales: 1.71
- Book Value: $17.20 per share
- Price / Book: 1.82
Profitability:- EBIDTA: $43.51 million
- Net Margins: 0.30%
- Return on Equity: 7.39%
- Return on Assets: 5.98%
Debt:- Debt-to-Equity Ratio: 0.06%
- Current Ratio: 4.15%
- Quick Ratio: 2.18%
Misc:- Average Volume: 31,070 shs.
- Beta: 1.02
- Short Ratio: 4.2
Frequently Asked Questions for Exactech (NASDAQ:EXAC)
What is Exactech's stock symbol?
Exactech trades on the NASDAQ under the ticker symbol "EXAC."
How were Exactech's earnings last quarter?
Exactech, Inc. (NASDAQ:EXAC) issued its quarterly earnings data on Thursday, July, 27th. The company reported $0.33 earnings per share for the quarter, meeting analysts' consensus estimates of $0.33. The firm earned $67.30 million during the quarter, compared to analyst estimates of $67.75 million. Exactech had a return on equity of 7.39% and a net margin of 0.30%. Exactech's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.31 EPS. View Exactech's Earnings History.
When will Exactech make its next earnings announcement?
What guidance has Exactech issued on next quarter's earnings?
Exactech issued an update on its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $1.27-1.31 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.30. The company issued revenue guidance of $267-271 million, compared to the consensus revenue estimate of $270.33 million.Exactech also updated its Q3 guidance to $0.23-0.25 EPS.
Who are some of Exactech's key competitors?
Some companies that are related to Exactech include Orthofix International N.V. (OFIX), Intersect ENT (XENT), AtriCure (ATRC), CryoLife (CRY), Landauer (LDR), Meridian Bioscience (VIVO), Invacare Corporation (IVC), Consort Medical plc (CSRT), Antares Pharma (ATRS), STAAR Surgical Company (STAA), Sientra (SIEN), Utah Medical Products (UTMD), Transenterix (TRXC), Transenterix (TRXC), Ocular Therapeutix (OCUL), T2 Biosystems (TTOO), SeaSpine Holdings Corporation (SPNE) and Bioquell plc (BQE).
Who are Exactech's key executives?
Exactech's management team includes the folowing people:
- R. William Petty M.D., Executive Chairman of the Board
- David W. Petty, Chief Executive Officer, President and Director
- Joel C. Phillips CPA, Chief Financial Officer, Executive Vice President, Treasurer
- Bruce E. Thompson, Senior Vice President , General manager- Biologics and Spine Division
- Gary J. Miller Ph.D., Executive Vice President - Research and Development
- Donna M. Edwards, Vice President, Legal and General Counsel
- Betty A. Petty, Vice President - Administration, Corporate Secretary
- James G. Binch, Independent Director
- W. Andrew Krusen Jr., Independent Director
- William B. Locander Ph.D., Independent Director
Who owns Exactech stock?
Exactech's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.78%), Gamco Investors INC. ET AL (4.33%), Acadian Asset Management LLC (3.01%), LSV Asset Management (2.95%), Vanguard Group Inc. (2.90%) and Royce & Associates LP (1.94%). Company insiders that own Exactech stock include Betty A Petty, Bruce E Thompson, David W Petty, Donna M Edwards, Fern Watts, Gary J Miller, James G Binch, Joel C Phillips and William B Locander. View Institutional Ownership Trends for Exactech.
Who sold Exactech stock? Who is selling Exactech stock?
Exactech's stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Foundry Partners LLC, Acadian Asset Management LLC, Schaper Benz & Wise Investment Counsel Inc. WI, Royce & Associates LP, Goldman Sachs Group Inc., Clean Yield Group and DAFNA Capital Management LLC. Company insiders that have sold Exactech stock in the last year include Bruce E Thompson, Fern Watts, James G Binch, Joel C Phillips and William B Locander. View Insider Buying and Selling for Exactech.
Who bought Exactech stock? Who is buying Exactech stock?
Exactech's stock was bought by a variety of institutional investors in the last quarter, including Gamco Investors INC. ET AL, FMR LLC, Thomson Horstmann & Bryant Inc., Algert Global LLC, Dimensional Fund Advisors LP, EAM Investors LLC, Teton Advisors Inc. and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Exactech.
How do I buy Exactech stock?
Shares of Exactech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Exactech's stock price today?
One share of Exactech stock can currently be purchased for approximately $31.30.
MarketBeat Community Rating for Exactech (NASDAQ EXAC)MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Exactech (NASDAQ:EXAC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Buy Rating |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Exactech (NASDAQ:EXAC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/31/2017 | Gabelli | Reiterated Rating | Buy | | High |  |
| 4/13/2016 | Robert W. Baird | Upgrade | Neutral -> Outperform | $21.00 -> $26.00 | N/A | |
| 10/28/2015 | Northland Securities | Lower Price Target | Market Perform | $22.00 -> $20.00 | N/A | |
(Data available from 9/24/2015 forward)
Earnings History for Exactech (NASDAQ:EXAC)Earnings History by Quarter for Exactech (NASDAQ EXAC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | $0.24 | | | | | N/A | |
| 7/27/2017 | Q2 2017 | $0.33 | $0.33 | $67.75 million | $67.30 million | View | N/A | |
| 4/25/2017 | Q1 2017 | $0.31 | $0.34 | $67.05 million | $69.48 million | View | N/A | |
| 2/21/2017 | Q416 | $0.32 | $0.34 | $66.00 million | $66.20 million | View | Listen | |
| 10/31/2016 | Q316 | $0.22 | $0.22 | $58.69 million | $59.90 million | View | N/A | |
| 8/1/2016 | Q216 | $0.30 | $0.31 | $64.18 million | $66.10 million | View | N/A | |
| 4/26/2016 | Q116 | $0.29 | $0.31 | $63.63 million | $65.30 million | View | N/A | |
| 2/16/2016 | Q415 | $0.28 | $0.29 | $61.29 million | $62.70 million | View | Listen | |
| 10/27/2015 | Q315 | $0.23 | $0.20 | $58.46 million | $56.20 million | View | Listen | |
| 7/28/2015 | Q215 | $0.27 | $0.26 | $62.13 million | $61.50 million | View | Listen | |
| 4/28/2015 | Q115 | $0.30 | $0.29 | $63.71 million | $61.40 million | View | N/A | |
| 2/17/2015 | Q414 | $0.33 | $0.36 | $63.30 million | $63.30 million | View | N/A | |
| 10/21/2014 | Q314 | $0.25 | $0.21 | $58.60 million | $57.90 million | View | N/A | |
| 7/28/2014 | Q214 | $0.30 | $0.30 | $63.80 million | $63.92 million | View | N/A | |
| 4/21/2014 | Q114 | $0.29 | $0.30 | $63.05 million | $63.30 million | View | N/A | |
| 2/19/2014 | Q413 | $0.31 | $0.33 | $63.20 million | $61.60 million | View | N/A | |
| 10/22/2013 | Q313 | $0.21 | $0.23 | $55.36 million | $55.70 million | View | N/A | |
| 7/23/2013 | Q2 2013 | $0.25 | $0.27 | $58.42 million | $60.60 million | View | N/A | |
| 2/26/2013 | Q4 2012 | $0.28 | $0.29 | $58.20 million | $59.30 million | View | N/A | |
| 10/30/2012 | Q312 | $0.17 | $0.19 | $50.20 million | $51.30 million | View | N/A | |
| 7/31/2012 | | $0.23 | $0.23 | | | View | N/A | |
| 5/1/2012 | | $0.23 | $0.25 | | | View | N/A | |
| 2/28/2012 | | $0.25 | $0.18 | | | View | N/A | |
| 11/1/2011 | | $0.20 | $0.15 | | | View | N/A | |
| 8/2/2011 | | $0.26 | $0.28 | | | View | N/A | |
| 5/3/2011 | | $0.27 | $0.28 | | | View | N/A | |
| 2/28/2011 | | $0.23 | $0.23 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Exactech (NASDAQ:EXAC)Current Year EPS Consensus Estimate: $1.29 EPS
Next Year EPS Consensus Estimate: $1.47 EPS
Dividend History for Exactech (NASDAQ:EXAC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Exactech (NASDAQ:EXAC)Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 64.58%
Insider Trades by Quarter for Exactech (NASDAQ:EXAC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/8/2017 | Fern Watts | Director | Sell | 1,013 | $29.04 | $29,417.52 | |
| 8/4/2017 | James G Binch | Director | Sell | 747 | $28.40 | $21,214.80 | |
| 5/31/2017 | William B Locander | Director | Sell | 988 | $30.34 | $29,975.92 | |
| 5/23/2017 | Joel C Phillips | CFO | Sell | 7,610 | $30.71 | $233,703.10 | |
| 3/9/2017 | Fern Watts | Director | Sell | 1,000 | $24.25 | $24,250.00 | |
| 3/8/2017 | James G Binch | Director | Sell | 3,588 | $24.16 | $86,686.08 | |
| 2/24/2017 | Bruce E Thompson | SVP | Sell | 4,906 | $24.77 | $121,521.62 | |
| 11/3/2016 | James G Binch | Director | Sell | 600 | $22.61 | $13,566.00 | |
| 8/25/2016 | Fern Watts | Director | Sell | 1,100 | $27.68 | $30,448.00 | |
| 8/22/2016 | Bruce E Thompson | SVP | Sell | 1,433 | $27.97 | $40,081.01 | |
| 8/19/2016 | David W Petty | CEO | Sell | 3,550 | $27.75 | $98,512.50 | |
| 7/1/2016 | Joel C Phillips | CFO | Sell | 3,000 | $26.75 | $80,250.00 | |
| 6/8/2016 | Gary J Miller | EVP | Sell | 9,800 | $25.16 | $246,568.00 | |
| 6/7/2016 | Bruce E Thompson | SVP | Sell | 2,000 | $25.07 | $50,140.00 | |
| 6/3/2016 | James G Binch | Director | Sell | 600 | $24.86 | $14,916.00 | |
| 6/2/2016 | Gary J Miller | EVP | Sell | 3,381 | $25.11 | $84,896.91 | |
| 5/25/2016 | Gary J Miller | EVP | Sell | 9,319 | $25.10 | $233,906.90 | |
| 5/18/2016 | Gary J Miller | EVP | Sell | 9,664 | $24.37 | $235,511.68 | |
| 5/9/2016 | Joel C Phillips | CFO | Sell | 3,900 | $23.13 | $90,207.00 | |
| 5/5/2016 | James G Binch | Director | Sell | 1,870 | $23.00 | $43,010.00 | |
| 5/3/2016 | Fern Watts | Director | Sell | 2,000 | $22.76 | $45,520.00 | |
| 4/29/2016 | Betty A Petty | VP | Sell | 18,000 | $22.65 | $407,700.00 | |
| 4/27/2016 | Gary J Miller | EVP | Sell | 9,851 | $24.06 | $237,015.06 | |
| 4/26/2016 | Gary J Miller | EVP | Sell | 7,985 | $23.11 | $184,533.35 | |
| 4/25/2016 | Gary J Miller | EVP | Sell | 4,725 | $23.14 | $109,336.50 | |
| 3/31/2016 | Gary J Miller | EVP | Sell | 7,000 | $19.95 | $139,650.00 | |
| 3/10/2016 | Joel C Phillips | CFO | Sell | 2,000 | $18.58 | $37,160.00 | |
| 3/8/2016 | Betty A Petty | VP | Sell | 15,964 | $19.06 | $304,273.84 | |
| 3/7/2016 | Donna M Edwards | VP | Sell | 10,000 | $18.85 | $188,500.00 | |
| 3/3/2016 | Gary J Miller | EVP | Sell | 7,017 | $19.23 | $134,936.91 | |
| 3/3/2016 | William B Locander | Director | Sell | 2,435 | $19.25 | $46,873.75 | |
| 12/10/2015 | James G Binch | Director | Sell | 1,500 | $17.03 | $25,545.00 | |
| 12/9/2015 | Fern Watts | Director | Sell | 1,200 | $17.32 | $20,784.00 | |
| 12/1/2015 | Bruce E. Thompson | SVP | Sell | 21,904 | $17.57 | $384,853.28 | |
| 11/24/2015 | Bruce E. Thompson | SVP | Sell | 900 | $17.75 | $15,975.00 | |
| 9/1/2015 | Bruce E. Thompson | SVP | Sell | 2,107 | $19.45 | $40,981.15 | |
| 5/28/2015 | Joel C Phillips | CFO | Sell | 5,000 | $21.76 | $108,800.00 | |
| 5/20/2015 | William B Locander | Director | Sell | 3,350 | $21.50 | $72,025.00 | |
| 5/18/2015 | Fern Watts | Director | Sell | 2,200 | $21.21 | $46,662.00 | |
| 5/4/2015 | Joel C Phillips | CFO | Sell | 2,700 | $21.67 | $58,509.00 | |
| 3/20/2015 | Gary J Miller | EVP | Sell | 32,800 | $24.95 | $818,360.00 | |
| 2/24/2015 | R William Petty | Chairman | Sell | 45,067 | $23.08 | $1,040,146.36 | |
| 2/2/2015 | Betty A Petty | VP | Sell | 7,500 | $20.74 | $155,550.00 | |
| 1/8/2015 | Gary J Miller | EVP | Sell | 4,145 | $23.17 | $96,039.65 | |
| 12/3/2014 | Gary J Miller | EVP | Sell | 5,000 | $21.83 | $109,150.00 | |
| 11/25/2014 | Betty A Petty | Major Shareholder | Sell | 12,500 | $21.86 | $273,250.00 | |
| 11/25/2014 | Bruce E Thompson | SVP | Sell | 6,500 | $22.05 | $143,325.00 | |
| 10/31/2014 | Joel C Phillips | CFO | Sell | 5,000 | $21.44 | $107,200.00 | |
| 9/5/2014 | R William Petty | Major Shareholder | Sell | 25,000 | $23.68 | $592,000.00 | |
| 8/25/2014 | Albert H Burstein | Director | Sell | 8,852 | $23.73 | $210,057.96 | |
| 7/1/2014 | Gary J Miller | EVP | Sell | 12,392 | $26.21 | $324,794.32 | |
| 6/26/2014 | Gary J Miller | EVP | Sell | 1,894 | $25.06 | $47,463.64 | |
| 6/25/2014 | Gary J Miller | EVP | Sell | 16,356 | $25.33 | $414,297.48 | |
| 6/10/2014 | Joel C Phillips | CFO | Sell | 5,000 | $24.77 | $123,850.00 | |
| 6/5/2014 | Bruce E Thompson | SVP | Sell | 1,667 | $23.50 | $39,174.50 | |
| 6/5/2014 | Joel C Phillips | CFO | Sell | 5,000 | $23.21 | $116,050.00 | |
| 5/29/2014 | Bruce E Thompson | SVP | Sell | 1,588 | $23.00 | $36,524.00 | |
| 5/12/2014 | David Petty | CEO | Sell | 10,287 | $20.99 | $215,924.13 | |
| 5/8/2014 | David Petty | CEO | Sell | 7,976 | $21.51 | $171,563.76 | |
| 4/24/2014 | Bruce Thompson | SVP | Sell | 2,412 | $23.78 | $57,357.36 | |
| 4/23/2014 | William Locander | Director | Sell | 4,500 | $23.18 | $104,310.00 | |
| 2/28/2014 | William Locander | Director | Sell | 1,819 | $23.16 | $42,128.04 | |
| 12/5/2013 | R William Petty | CEO | Sell | 10,000 | $23.67 | $236,700.00 | |
| 11/12/2013 | Bruce Thompson | SVP | Sell | 3,079 | $23.35 | $71,894.65 | |
| 8/22/2013 | William Locander | Director | Sell | 1,521 | $19.05 | $28,975.05 | |
| 7/15/2013 | Gary J Miller | EVP | Sell | 10,250 | $20.07 | $205,717.50 | |
| 7/8/2013 | Gary J Miller | EVP | Sell | 1,000 | $20.00 | $20,000.00 | |
| 6/17/2013 | Gary J Miller | EVP | Sell | 8,125 | $18.98 | $154,212.50 | |
| 6/5/2013 | R William Petty | CEO | Sell | 3,885 | $18.00 | $69,930.00 | |
| 6/4/2013 | R William Petty | CEO | Sell | 14,257 | $18.01 | $256,768.57 | |
| 5/28/2013 | R William Petty | CEO | Sell | 20,000 | $18.21 | $364,200.00 | |
| 5/22/2013 | R William Petty | CEO | Sell | 11,493 | $18.13 | $208,368.09 | |
| 5/17/2013 | R William Petty | CEO | Sell | 17,472 | $18.05 | $315,369.60 | |
| 5/16/2013 | R William Petty | CEO | Sell | 22,893 | $18.22 | $417,110.46 | |
| 5/9/2013 | R William Petty | CEO | Sell | 10,000 | $18.25 | $182,500.00 | |
| 5/8/2013 | David W Petty | President | Sell | 8,000 | $18.35 | $146,800.00 | |
| 12/4/2012 | R William Petty | CEO | Sell | 14,048 | $16.29 | $228,841.92 | |
(Data available from 1/1/2013 forward)
Headline Trends for Exactech (NASDAQ:EXAC)
Latest Headlines for Exactech (NASDAQ:EXAC)
| Source: |
|
| Date | Headline |
|---|
 | Head to Head Review: Exactech (EXAC) vs. SeaSpine Holdings Corporation (SPNE)
www.americanbankingnews.com - September 16 at 6:30 PM |
| Head-To-Head Contrast: Exactech (EXAC) & Transenterix (TRXC)
www.americanbankingnews.com - September 14 at 6:04 PM |
 | Global Knee Reconstruction Market Value to Reach US$9.4 Bn by 2022 - Future Market Insights
www.prnewswire.com - September 13 at 7:52 PM |
 | Exactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : September 11, 2017
finance.yahoo.com - September 11 at 7:05 PM |
| Analyzing Exactech (EXAC) & CONMED Corporation (CNMD)
www.americanbankingnews.com - September 10 at 12:26 PM |
 | Form 4 EXACTECH INC For: Aug 31 Filed by: KRUSEN W ANDREW JR
www.streetinsider.com - September 6 at 1:10 AM |
| Exactech To Present to Investors at Baird 2017 Global Healthcare Conference
finance.yahoo.com - September 5 at 8:10 PM |
| Exactech (EXAC) Truliant Knee System Receives IDEA Award
finance.yahoo.com - August 22 at 7:05 PM |
| Exactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : August 21, 2017
finance.yahoo.com - August 21 at 6:01 PM |
| Exactech’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)
finance.yahoo.com - August 21 at 6:01 PM |
| Exactech, Inc. (EXAC) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - August 19 at 11:50 AM |
| Insider Selling: Exactech, Inc. (NASDAQ:EXAC) Director Sells 1,013 Shares of Stock
www.americanbankingnews.com - August 10 at 8:38 PM |
| Exactech, Inc. (NASDAQ:EXAC) Director James G. Binch Sells 747 Shares
www.americanbankingnews.com - August 8 at 8:34 PM |
| MiMedx Group (MDXG) vs. Exactech (NASDAQ:EXAC) Financial Comparison
www.americanbankingnews.com - August 5 at 4:18 PM |
| Exactech, Inc. – Value Analysis (NASDAQ:EXAC) : August 1, 2017
finance.yahoo.com - August 1 at 7:10 PM |
| Gabelli Weighs in on Exactech, Inc.'s FY2019 Earnings (EXAC)
www.americanbankingnews.com - August 1 at 3:30 PM |
| Exactech's (NASDAQ:EXAC) Buy Rating Reiterated at Gabelli
www.americanbankingnews.com - July 31 at 9:22 PM |
| Exactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : July 31, 2017
finance.yahoo.com - July 31 at 6:14 PM |
| Edited Transcript of EXAC earnings conference call or presentation 28-Jul-17 2:00pm GMT
finance.yahoo.com - July 29 at 5:39 PM |
| Exactech, Inc. (EXAC) Announces Earnings Results, Meets Expectations
www.americanbankingnews.com - July 29 at 1:52 PM |
 | BRIEF-Exactech Q2 earnings per share $0.33
www.businessinsider.com - July 28 at 9:42 PM |
 | Exactech's (EXAC) CEO David Petty on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 9:42 PM |
| Investor Network: Exactech, Inc. to Host Earnings Call
finance.yahoo.com - July 28 at 4:37 PM |
| Exactech posts 2Q profit
finance.yahoo.com - July 28 at 4:37 PM |
| Exactech, Inc. (NASDAQ:EXAC) Releases FY17 Earnings Guidance
www.americanbankingnews.com - July 27 at 9:40 PM |
| Exactech, Inc. (EXAC) Issues Q3 Earnings Guidance
www.americanbankingnews.com - July 27 at 9:40 PM |
| Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue
finance.yahoo.com - July 27 at 7:00 PM |
| Exactech, Inc. breached its 50 day moving average in a Bullish Manner : EXAC-US : July 18, 2017
finance.yahoo.com - July 18 at 7:57 PM |
| Exactech, Inc. (EXAC) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - July 18 at 11:34 AM |
| Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call
finance.yahoo.com - July 13 at 7:49 PM |
| Exactech Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement
finance.yahoo.com - June 29 at 4:49 PM |
| Exactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : June 28, 2017
finance.yahoo.com - June 28 at 6:10 PM |
| Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems
finance.yahoo.com - June 22 at 9:53 AM |
| ETFs with exposure to Exactech, Inc. : June 19, 2017
finance.yahoo.com - June 19 at 6:22 PM |
| Exactech, Inc. :EXAC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 3:53 PM |
| Alteon® HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech
finance.yahoo.com - June 12 at 5:57 PM |
| Exactech Announces Successful First Surgeries with New Equinoxe® Preserve Stem and ExactechGPS® Shoulder Application
finance.yahoo.com - June 6 at 5:29 PM |
| Exactech, Inc. (EXAC) Director Sells $29,975.92 in Stock
www.americanbankingnews.com - June 1 at 8:32 PM |
| Exactech Announces Successful First Surgeries with Truliant® Knee System
finance.yahoo.com - May 31 at 9:29 AM |
| Exactech, Inc. (EXAC) Short Interest Update
www.americanbankingnews.com - May 26 at 9:45 AM |
| Joel C. Phillips Sells 7,610 Shares of Exactech, Inc. (EXAC) Stock
www.americanbankingnews.com - May 25 at 8:06 PM |
| Exactech (EXAC) Gets FDA Approval for ExactechGPS Application
finance.yahoo.com - May 19 at 5:40 AM |
| Exactech (EXAC) Gains FDA 510(k) Clearance for ExactechGPS Shoulder Application
www.streetinsider.com - May 16 at 10:02 PM |
| Exactech Receives 510(k) Clearance for Computer-Assisted Shoulder Arthroplasty Technology
finance.yahoo.com - May 15 at 11:35 AM |
| Exactech (EXAC) Getting Favorable Press Coverage, Study Shows
www.americanbankingnews.com - May 3 at 12:14 AM |
 | Ventricular Assist Device (VAD) Market Forecast 2017-2027
www.marketwatch.com - May 2 at 7:32 PM |
| Exactech, Inc. (EXAC) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - May 1 at 9:28 PM |
| FY2018 EPS Estimates for Exactech, Inc. (EXAC) Lifted by Analyst
www.americanbankingnews.com - May 1 at 2:00 PM |
| FY2021 Earnings Forecast for Exactech, Inc. Issued By Gabelli (EXAC)
www.americanbankingnews.com - April 29 at 12:48 AM |
 | BRIEF-Exactech reports Q1 earnings per share $0.32
www.reuters.com - April 27 at 10:43 PM |
Exactech (EXAC) Chart for Sunday, September, 24, 2017
